Unleashing the Potential of the Belgian ATMP Sector
No single organization possesses the knowledge, resources and capabilities required to bring affordable, advanced therapy medicinal products (ATMP) and breakthrough healthcare benefits to patients worldwide. Collaboration between public and private stakeholders across the ‘quadruple helix’ – academia, industry, government, patients – is a critical success factor if the promise of moving from ‘care-to-cure’ is to be realized.
Events and Webinars
